Novartis Aktie
121,85
EUR
±0,00
EUR
±0,00
%
113,54
CHF
-0,22
CHF
-0,19
%
Werbung
Novartis Aktie Analyse
| 21.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 21.06.17 | Novartis Hold | Deutsche Bank AG | |
| 21.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 08.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.06.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 02.06.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 24.05.17 | Novartis Neutral | UBS AG | |
| 19.05.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.05.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 26.04.17 | Novartis Hold | Deutsche Bank AG | |
| 25.04.17 | Novartis Hold | S&P Capital IQ | |
| 21.04.17 | Novartis Neutral | UBS AG | |
| 18.04.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 11.04.17 | Novartis Hold | Deutsche Bank AG | |
| 06.04.17 | Novartis Neutral | UBS AG | |
| 23.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 23.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.03.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 17.03.17 | Novartis Hold | Deutsche Bank AG | |
| 15.03.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.03.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 14.03.17 | Novartis Neutral | UBS AG | |
| 10.03.17 | Novartis Hold | Deutsche Bank AG | |
| 06.02.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 31.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 30.01.17 | Novartis Neutral | UBS AG | |
| 26.01.17 | Novartis Hold | Deutsche Bank AG | |
| 25.01.17 | Novartis Hold | S&P Capital IQ | |
| 24.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 24.01.17 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 19.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 16.01.17 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.01.17 | Novartis Hold | Deutsche Bank AG | |
| 03.01.17 | Novartis Neutral | JP Morgan Chase & Co. | |
| 13.12.16 | Novartis Hold | Deutsche Bank AG | |
| 08.12.16 | Novartis Neutral | UBS AG | |
| 30.11.16 | Novartis Hold | Deutsche Bank AG | |
| 26.10.16 | Novartis Hold | Deutsche Bank AG | |
| 25.10.16 | Novartis Hold | S&P Capital IQ | |
| 19.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.10.16 | Novartis Hold | Deutsche Bank AG | |
| 10.10.16 | Novartis Hold | Deutsche Bank AG | |
| 10.10.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 14.09.16 | Novartis Neutral | BNP PARIBAS | |
| 04.08.16 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 20.07.16 | Novartis Neutral | UBS AG | |
Werbung
Werbung